What is the impact of COVID-19 on adult patients with type 2 diabetes (T2D) and how do we navigate healthcare when an epidemic and pandemic seemingly join forces to further exacerbate patient outcomes? Join experts in T2D: Dr. John Anderson (primary care provider), Dr. Eden Miller (primary care provider), and Dr. Serge Jabbour (endocrinologist) for an in-depth discussion on how COVID-19 impacts patients with T2D and what you can do to help your patients as new information is discovered during this evolving landscape.

This podcast is sponsored by Novo Nordisk and is intended for clinicians. The opinions expressed are those of the speakers and not Novo Nordisk.

Faculty Presenters:

John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

Eden Miller, DO, FOMA
Diabetes Care, Obesity, Family Medicine
Founder, Diabetes and Obesity Care, LLC
Bend, Oregon

Serge A. Jabbour, MD, FACP, FACE
Diabetes, Clinical Trials of Diabetes Treatments, Obesity
Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolic Diseases
Director, Jefferson Diabetes Center, Division of Endocrinology, Diabetes and Metabolic Diseases
Sidney Kimmel Medical College/ Thomas Jefferson University
Philadelphia, PA